Keros Therapeutics Inc. Revenue 2019–2025
Keros Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Keros Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 367000, a 99.83% decrease year-over-year.
- Keros Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 244.0 M, a 47195.16% increase year-over-year.
- Keros Therapeutics Inc. annual revenue for 2025 was 244.1 M, a 6774.96% increase from 2024.
- Keros Therapeutics Inc. annual revenue for 2024 was 3.5 M, a 2250.99% increase from 2023.
- Keros Therapeutics Inc. annual revenue for 2023 was 151000.
- Keros Therapeutics Inc. annual revenue for 2022 was 0.
Keros Therapeutics Inc. (KROS) — Frequently Asked Questions
Keros Therapeutics Inc. (KROS) is a publicly traded US company. It has a market capitalization of $376M. In fiscal 2025 it reported revenue of $244M and net income of $87M. Explore KROS's stock price, financial statements, earnings history, margins and key ratios below.
What is Keros Therapeutics Inc.'s market cap?
Keros Therapeutics Inc. (KROS) has a market capitalization of $376M.
What is the KROS stock price?
KROS trades at $9.93 (-1.39% on the day).
How much revenue does Keros Therapeutics Inc. make?
Keros Therapeutics Inc. reported revenue of $244M in fiscal 2025.
Is KROS profitable?
In fiscal 2025, Keros Therapeutics Inc. reported net income of $87M.